SCHEMBL26327646

SCHEMBL26327646

CCCOC(=O)C(C(=O)OCCC)N(C1CC1)C1CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPM1B O75688 1/20 0.37
PTPN1 P18031 1/20 0.37
PPP1CC P36873 1/20 0.37
HCAR2 Q8TDS4 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 2/20 0.32
CYP3A4 P08684 2/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
ADRA1A P35348 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KCNH2 Q12809 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26327648 0.96 ADH1A (0.37) PPM1BPTPN1PPP1CCALDH1A1LMNA
SCHEMBL26328040 0.94 ADH1A (0.38) PPM1BPTPN1PPP1CCALDH1A1LMNA
SCHEMBL26327651 0.73 LMNA (0.44) ALDH1A1LMNACYP3A4CHRM2HTR1A
SCHEMBL20564725 0.72 TSHR (0.36) TSHR
SCHEMBL26328045 0.69 HCAR2 (0.36) HCAR2ALDH1A1LMNACHRM1SLC6A2
SCHEMBL6063003 0.69 L3MBTL1 (0.44) PPM1BPTPN1PPP1CCHCAR2ALDH1A1
SCHEMBL25440013 0.69 TSHR (0.38) TSHRADH1A
SCHEMBL26327623 0.68 CHRNB2 (0.39) HCAR2ALDH1A1LMNACHRM1SLC6A2
SCHEMBL28869989 0.68 TSHR (0.40) PPM1BPTPN1PPP1CCALDH1A1LMNA
SCHEMBL16732324 0.67 TSHR (0.39) PPM1BPTPN1PPP1CCALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 PPM1B 2421/4885PTPN1 4457/4885PPP1CC 3337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.